Featured Videos |view more
Video
Limb Salvage Surgery for Pediatric Bone Sarcoma
MUSC is one of a few centers in the country that offers advanced skeletal reconstruction and limb salvage surgery for pediatric bone sarcomas.
Video
Awake Craniotomy and Tumor Resection
Abhay Varma, M.D., MUSC Health neurosurgeon at the Hollings Cancer Center, discusses the awake craniotomy and tumor resection procedure.
Video
Gamma Knife Surgery for Brain Tumors
Gamma Knife Radiosurgery is a service offered by MUSC for treatment of brain tumors, pain syndromes, arteriovenous malformations, epilepsy, and psychiatric disorders.
Video
Robotic Abdominoperineal Resection With Robotic Flap Harvest for Vaginal Reconstruction
Although technically challenging, robotic abdominoperineal resection (APR) with robotic harvest of the rectus abdominus muscular flap can eliminate the need for a midline laparotomy, reduce wound infection rates and lead to faster recovery.
Video
Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Video
New Rule-Out Test for Lung Cancer Increases Diagnostic Precision
Gerard A. Silvestri, M.D., a lung cancer pulmonologist at MUSC, led a study that shows that a new biomarker is 98 percent effective at distinguishing benign from malignant lung nodules.
Featured Articles and Documents |view more
News
MUSC Researchers Aim to Link the Microbiome to Health and Disease
To ensure its clinicians and researchers can help create new microbiome-based therapies, MUSC is ramping up its microbiome infrastructure, providing support in sequencing the microbiota and in analyzing the resulting datasets.
News
A New Link Between Cancer and Aging
Scientists at MUSC Hollings Cancer Center have found that lung cancer cells resist dying by affecting the aging process. The discovery could help us better understand aging and eventually lead to new treatments for cancer.
News
Low PTEN in Normal Breast Cells Can Prevent Successful Radiotherapy
News
Snapshot of immune system proteins predicts patients’ response to immunotherapy.
News
A novel noninvasive therapy, tumor-treating fields (TTFields), extends survival by five months in recurrent glioblastoma disease.
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.
